Paediatric Rheumatology
The sponsor’s clinical research activity is centred on juvenile idiopathic arthritis, with a focus on children affected by polyarticular course juvenile idiopathic arthritis and persistent inflammatory joint disease.
- Juvenile idiopathic arthritis
- Polyarticular course juvenile idiopathic arthritis
- Childhood inflammatory arthritis
Its research interest includes treatment strategies for paediatric patients whose disease remains active after prior TNF inhibitor therapy.
Biologic Treatment Sequencing
The funded research examines the use of sequential biologic therapies in rheumatoid spectrum inflammatory disease, with particular attention to switching between TNF inhibitors and non-TNFi medications.
- TNF inhibitor failure
- Non-TNFi medications
- Therapy switching
This area reflects a therapeutic interest in selecting effective next-line options for children with ongoing synovitis and treatment-resistant disease.
Disease Control and Remission
The clinical focus includes achieving minimal disease activity in paediatric arthritis, with attention to improvement in joint inflammation and disease burden over time.
- Minimal disease activity
- Clinical disease control
- Inflammatory arthritis outcomes
Outcome interests are directed toward measures of symptom reduction and functional improvement in children with refractory arthritis.
Multinational Collaborative Research
The sponsor’s trial portfolio includes work conducted across multiple countries and collaborating research sites, supporting shared investigation in paediatric autoimmune disease.
- International site collaboration
- Paediatric autoimmune research
- Cross-border trial participation
This research setting is aligned with the study of uncommon paediatric rheumatic conditions requiring coordinated clinical expertise.
